Polyxane Mertzanis

1.7k total citations
17 papers, 1.3k citations indexed

About

Polyxane Mertzanis is a scholar working on Pharmacology, Dermatology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Polyxane Mertzanis has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Dermatology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Polyxane Mertzanis's work include Pharmacogenetics and Drug Metabolism (5 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Allergic Rhinitis and Sensitization (4 papers). Polyxane Mertzanis is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Allergic Rhinitis and Sensitization (4 papers). Polyxane Mertzanis collaborates with scholars based in United States, Canada and United Kingdom. Polyxane Mertzanis's co-authors include Linda Abetz, Robin L. Chalmers, Carolyn G. Begley, Trefford Simpson, Timothy B. Edrington, Christopher W. Snyder, Krithika Rajagopalan, Jennifer A. Graf, Jerold S. Harmatz and Richard I. Shader and has published in prestigious journals such as Pain, Clinical Pharmacology & Therapeutics and Investigative Ophthalmology & Visual Science.

In The Last Decade

Polyxane Mertzanis

17 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Polyxane Mertzanis United States 13 751 320 300 227 186 17 1.3k
Donald J. Kellerman United States 14 171 0.2× 63 0.2× 91 0.3× 21 0.1× 70 0.4× 29 1.1k
John P. Gonzalez United Kingdom 13 130 0.2× 28 0.1× 16 0.1× 31 0.1× 8 0.0× 26 918
Daniel P. Wermeling United States 22 403 0.5× 15 0.0× 3 0.0× 142 0.6× 30 0.2× 56 1.7k
Abraham Sunshine United States 27 239 0.3× 5 0.0× 24 0.1× 17 0.1× 22 0.1× 71 2.0k
Dinesh Badyal India 15 305 0.4× 16 0.1× 10 0.0× 20 0.1× 44 0.2× 97 843
Alberto Vaccheri Italy 25 60 0.1× 17 0.1× 24 0.1× 11 0.0× 20 0.1× 74 1.5k
Ralph Edwards Sweden 10 327 0.4× 5 0.0× 54 0.2× 77 0.3× 17 0.1× 15 727
Eric Wooltorton Canada 16 77 0.1× 6 0.0× 19 0.1× 36 0.2× 24 0.1× 66 1.0k
Neil C Abbot United Kingdom 15 59 0.1× 7 0.0× 8 0.0× 38 0.2× 132 0.7× 37 994
David Wesche United States 26 616 0.8× 3 0.0× 38 0.1× 17 0.1× 12 0.1× 57 2.2k

Countries citing papers authored by Polyxane Mertzanis

Since Specialization
Citations

This map shows the geographic impact of Polyxane Mertzanis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Polyxane Mertzanis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Polyxane Mertzanis more than expected).

Fields of papers citing papers by Polyxane Mertzanis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Polyxane Mertzanis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Polyxane Mertzanis. The network helps show where Polyxane Mertzanis may publish in the future.

Co-authorship network of co-authors of Polyxane Mertzanis

This figure shows the co-authorship network connecting the top 25 collaborators of Polyxane Mertzanis. A scholar is included among the top collaborators of Polyxane Mertzanis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Polyxane Mertzanis. Polyxane Mertzanis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Abetz, Linda, Diana Rofail, Polyxane Mertzanis, et al.. (2009). Alzheimer’s disease treatment: Assessing caregiver preferences for mode of treatment delivery. Advances in Therapy. 26(6). 627–644. 21 indexed citations
3.
Rajagopalan, Krithika, Linda Abetz, Polyxane Mertzanis, et al.. (2005). Comparing the Discriminative Validity of Two Generic and One Disease-Specific Health-Related Quality of Life Measures in a Sample of Patients with Dry Eye. Value in Health. 8(2). 168–174. 87 indexed citations
4.
Evans, Christopher J., Elyse Trudeau, Polyxane Mertzanis, et al.. (2004). Development and validation of the pain treatment satisfaction scale (ptss): a patient satisfaction questionnaire for use in patients with chronic or acute pain. Pain. 112(3). 254–266. 85 indexed citations
5.
Mertzanis, Polyxane, Linda Abetz, Krithika Rajagopalan, et al.. (2004). The Relative Burden of Dry Eye in Patients’ Lives: Comparisons to a U.S. Normative Sample. Investigative Ophthalmology & Visual Science. 46(1). 46–46. 210 indexed citations
6.
Greenblatt, David J., Lisa L. von Moltke, Jerold S. Harmatz, et al.. (2003). Short‐Term Exposure to Low‐Dose Ritonavir Impairs Clearance and Enhances Adverse Effects of Trazodone. The Journal of Clinical Pharmacology. 43(4). 414–422. 48 indexed citations
7.
Abetz, Linda, K. Venkataraman, Polyxane Mertzanis, Robin L. Chalmers, & Carolyn G. Begley. (2003). The Development, Reliability and Validity of a Questionnaire to Assess the Impact of Dry Eyes on Everyday Life (IDEEL). Investigative Ophthalmology & Visual Science. 44(13). 2477–2477. 3 indexed citations
8.
Evans, Christopher J., Polyxane Mertzanis, & Linda Abetz. (2003). Measurement strategies for indirect costs in economic evaluations. Expert Review of Pharmacoeconomics & Outcomes Research. 3(6). 703–716. 4 indexed citations
9.
Begley, Carolyn G., Robin L. Chalmers, Linda Abetz, et al.. (2003). The Relationship between Habitual Patient-Reported Symptoms and Clinical Signs among Patients with Dry Eye of Varying Severity. Investigative Ophthalmology & Visual Science. 44(11). 4753–4753. 347 indexed citations
10.
Abetz, Linda, et al.. (2002). ASSESSING THE IMPACT OF DRY EYES ON EVERYDAY LIFE.. Optometry and Vision Science. 79(Supplement). 304–304. 2 indexed citations
11.
Mertzanis, Polyxane, et al.. (2002). The Impact of Dry Eye on Daily Life: Results from a Qualitative Study. Investigative Ophthalmology & Visual Science. 43(13). 74–74. 1 indexed citations
12.
Venkatakrishnan, Karthik, Jürgen Schmider, Jerold S. Harmatz, et al.. (2001). Relative Contribution of CYP3A to Amitriptyline Clearance in Humans: In Vitro and In Vivo Studies. The Journal of Clinical Pharmacology. 41(10). 1043–1054. 49 indexed citations
13.
Greenblatt, David J., Lisa L. von Moltke, Jerold S. Harmatz, et al.. (2000). Differential Impairment of Triazolam and Zolpidem Clearance by Ritonavir. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(2). 129–136. 71 indexed citations
14.
Greenblatt, David J., Lisa L. von Moltke, Jerold S. Harmatz, et al.. (2000). Differential Impairment of Triazolam and Zolpidem Clearance by Ritonavir. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(2). 129–136. 23 indexed citations
15.
Greenblatt, David J., Lisa L. von Moltke, Jerold S. Harmatz, et al.. (1998). Inhibition of triazolam clearance by macrolide antimicrobial agents: In vitro correlates and dynamic consequences*. Clinical Pharmacology & Therapeutics. 64(3). 278–285. 65 indexed citations
16.
Greenblatt, David J., Lisa L. von Moltke, Jerold S. Harmatz, et al.. (1998). Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole*. Clinical Pharmacology & Therapeutics. 64(6). 661–671. 62 indexed citations
17.
Greenblatt, David J., Jerold S. Harmatz, Lisa L. von Moltke, et al.. (1998). Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo*. Clinical Pharmacology & Therapeutics. 64(5). 553–561. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donald J. Kellerman Breakdown of academic impact, for papers by John P. Gonzalez Breakdown of academic impact, for papers by Daniel P. Wermeling Breakdown of academic impact, for papers by Abraham Sunshine Breakdown of academic impact, for papers by Dinesh Badyal Breakdown of academic impact, for papers by Alberto Vaccheri Breakdown of academic impact, for papers by Ralph Edwards Breakdown of academic impact, for papers by Eric Wooltorton Breakdown of academic impact, for papers by Neil C Abbot Breakdown of academic impact, for papers by David Wesche
Rankless by CCL
2026